Teva Uk Limited

Real World Observational Study Suggests that QVAR(R) Particle Size, Formulation and Site of Action May Be Linked to Effective Asthma Control

Older News

CASTLEFORD, England, September 21, 2010 - Teva UK Limited (Nasdaq: TEVA) today announced the results of its real-life observational study, published in the September issue of the Journal of Asthma and Clinical Immunology.

MORE..